--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
Coinbase
COIN
MicroStrategy
MSTR
Meta Platforms
META
Apple
AAPL
Amazon
AMZN
US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 2.9300
- +0.0100+0.34%
Trading Dec 3 09:30 ET
3.09MMarket Cap-300P/E (TTM)
2.9300High2.9300Low767Volume2.9300Open2.9200Pre Close2.25KTurnover0.07%Turnover RatioLossP/E (Static)1.06MShares10.350052wk High0.63P/B3.08MFloat Cap2.167852wk Low--Dividend TTM1.05MShs Float3118.4994Historical High--Div YieldTTM0.00%Amplitude2.1670Historical Low2.9300Avg Price1Lot Size
Phio Pharmaceuticals Key Stats
Phio Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Phio Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.